|
|
| Research article summary (published 7 Jun 2009): |
|
Free Full Text! See links below |
Dose dependent effects of intravitreal triamcinolone acetonide on diffuse diabetic macular edema.
Full Abstract
PURPOSE: To evaluate the effect of different doses of intravitreal triamcinolone acetonide on diffuse diabetic macular edema. METHODS: In a retrospective study, 44 eyes with diffuse diabetic macular edema were treated with an intravitreal injection of 4 mg (n=12 eyes), 8 mg (n=17) or 25 mg (n=15) of triamcinolone acetonide (TA). Optical coherence tomography, best-corrected logMAR visual acuity and Goldmann tonometry were performed at baseline, 1 week, and 1, 3, 6, 9 and 12 months after treatment. Mean follow-up was 9.8 months (standard deviation=2.3) with a range of 5-12 months. RESULTS: The duration of intravitreal TA effects on macular thickness and visual acuity increased with increasing dosage. An observed increase in intraocular pressure induced by TA was not significantly associated with dosage. CONCLUSIONS: In patients with diffuse diabetic macular edema who receive intravitreal TA, effects may last longer after a dosage of 25 mg, than after lower doses of 8 mg or 4 mg.
Author information
Author/s: Bae, Joon Sung (JS); Park, Sung Joon (SJ); Ham, I Rum (IR); Lee, Tae Gon (TG);
Affiliation: Department of Ophthalmology, Konyang University, Kim's Eye Hospital, Seoul, Korea.
Journal and publication information
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
Journal: Korean journal of ophthalmology : KJO (Korean J Ophthalmol), published in Korea (South). (Language: eng)
Reference: 2009-Jun; vol 23 (issue 2) : pp 80-5
Dates: Created 2009/07/01; Completed 2009/09/15;
PMID: 19568355, status: MEDLINE (last retrieved date: 9/15/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Glucocorticoids (0) ; Triamcinolone Acetonide (76-25-5)Related articles
These are the most related articles currently in our database:
- Trans-Tenon's retrobulbar injection of triamcinolone acetonide for diffuse diabetic macular edema.
30 Oct 2005 - Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema.
Jul 2008 - Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
11 Mar 2006 - Intravitreal triamcinolone reinjection for refractory diabetic macular edema.
30 Aug 2006 - Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice.
30 May 2006 - Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology.
30 Jan 2005 - Diabetic macular edema before and after intravitreal triamcinolone injection.
30 May 2007 - Trans-Tenon's retrobulbar triamcinolone acetonide infusion for refractory diabetic macular edema after vitrectomy.
13 Jul 2005 - Follow-up after intravitreal triamcinolone acetonide for diabetic macular edema.
29 Jun 2006 - The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
30 May 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.